Neurosense Therapeutics (NRSN) Reports Q1, Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| (NASDAQ: NRSN) | Delayed: 2.67 -0.4 (13.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.07 | 52 Week High | $ | |||
| Open | $2.94 | 52 Week Low | $ | |||
| Day High | $2.94 | P/E | N/A | |||
| Day Low | $2.36 | EPS | $ | |||
| Volume | 117,600 | |||||
